메뉴 건너뛰기




Volumn 46, Issue , 2017, Pages 48-53

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study

Author keywords

Efficacy; Idiopathic Pulmonary Fibrosis; Pirfenidone; Safety; Severe

Indexed keywords

PIRFENIDONE; PLACEBO; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDONE DERIVATIVE;

EID: 85028328593     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2017.08.011     Document Type: Article
Times cited : (45)

References (36)
  • 4
    • 84891373517 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: on the move
    • Bouros, D., Tzouvelekis, A., Idiopathic pulmonary fibrosis: on the move. lancet Respir. Med. 2 (2014), 17–19.
    • (2014) lancet Respir. Med. , vol.2 , pp. 17-19
    • Bouros, D.1    Tzouvelekis, A.2
  • 6
    • 84942884150 scopus 로고    scopus 로고
    • Personalized medicine in idiopathic pulmonary fibrosis: facts and promises
    • Spagnolo, P., Tzouvelekis, A., Maher, T.M., Personalized medicine in idiopathic pulmonary fibrosis: facts and promises. Curr. Opin. Pulm. Med. 21 (2015), 470–478.
    • (2015) Curr. Opin. Pulm. Med. , vol.21 , pp. 470-478
    • Spagnolo, P.1    Tzouvelekis, A.2    Maher, T.M.3
  • 7
    • 84924744009 scopus 로고    scopus 로고
    • Update on therapeutic management of idiopathic pulmonary fibrosis
    • Tzouvelekis, A., Bonella, F., Spagnolo, P., Update on therapeutic management of idiopathic pulmonary fibrosis. Ther. Clin. risk Manag. 11 (2015), 359–370.
    • (2015) Ther. Clin. risk Manag. , vol.11 , pp. 359-370
    • Tzouvelekis, A.1    Bonella, F.2    Spagnolo, P.3
  • 8
    • 84881373734 scopus 로고    scopus 로고
    • Anti-acid treatment for idiopathic pulmonary fibrosis
    • Tzouvelekis, A., Bouros, D., Anti-acid treatment for idiopathic pulmonary fibrosis. lancet Respir. Med. 1 (2013), 348–349.
    • (2013) lancet Respir. Med. , vol.1 , pp. 348-349
    • Tzouvelekis, A.1    Bouros, D.2
  • 9
    • 84964226751 scopus 로고    scopus 로고
    • Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis
    • Tzouvelekis, A., Herazo-Maya, J., Sakamoto, K., Bouros, D., Biomarkers in the evaluation and management of idiopathic pulmonary fibrosis. Curr. Top. Med. Chem. 16 (2016), 1587–1598.
    • (2016) Curr. Top. Med. Chem. , vol.16 , pp. 1587-1598
    • Tzouvelekis, A.1    Herazo-Maya, J.2    Sakamoto, K.3    Bouros, D.4
  • 10
    • 84987662350 scopus 로고    scopus 로고
    • Lung transplantation in IIP: a review
    • Brown, A.W., Kaya, H., Nathan, S.D., Lung transplantation in IIP: a review. Respirology 21 (2016), 1173–1184.
    • (2016) Respirology , vol.21 , pp. 1173-1184
    • Brown, A.W.1    Kaya, H.2    Nathan, S.D.3
  • 11
    • 85006423756 scopus 로고    scopus 로고
    • Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient “Q and A” approach
    • Tzouvelekis, A., Tzilas, V., Papiris, S., Aidinis, V., Bouros, D., Diagnostic and prognostic challenges in Idiopathic Pulmonary Fibrosis A patient “Q and A” approach. Pulm. Pharmacol. Ther. 42 (2017), 21–24.
    • (2017) Pulm. Pharmacol. Ther. , vol.42 , pp. 21-24
    • Tzouvelekis, A.1    Tzilas, V.2    Papiris, S.3    Aidinis, V.4    Bouros, D.5
  • 13
    • 0032842405 scopus 로고    scopus 로고
    • Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis
    • Iyer, S.N., Gurujeyalakshmi, G., Giri, S.N., Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis. J. Pharmacol. Exp. Ther. 291 (1999), 367–373.
    • (1999) J. Pharmacol. Exp. Ther. , vol.291 , pp. 367-373
    • Iyer, S.N.1    Gurujeyalakshmi, G.2    Giri, S.N.3
  • 14
    • 85015353035 scopus 로고    scopus 로고
    • Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
    • Yu, W., Guo, F., Song, X., Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models. Pharm. Biol. 55 (2017), 450–455.
    • (2017) Pharm. Biol. , vol.55 , pp. 450-455
    • Yu, W.1    Guo, F.2    Song, X.3
  • 15
    • 48149113955 scopus 로고    scopus 로고
    • Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis
    • Oku, H., Shimizu, T., Kawabata, T., Nagira, M., Hikita, I., Ueyama, A., Matsushima, S., Torii, M., Arimura, A., Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis. Eur. J. Pharmacol. 590 (2008), 400–408.
    • (2008) Eur. J. Pharmacol. , vol.590 , pp. 400-408
    • Oku, H.1    Shimizu, T.2    Kawabata, T.3    Nagira, M.4    Hikita, I.5    Ueyama, A.6    Matsushima, S.7    Torii, M.8    Arimura, A.9
  • 16
    • 79956356774 scopus 로고    scopus 로고
    • Pirfenidone for idiopathic pulmonary fibrosis
    • Bouros, D., Pirfenidone for idiopathic pulmonary fibrosis. Lancet 377 (2011), 1727–1729.
    • (2011) Lancet , vol.377 , pp. 1727-1729
    • Bouros, D.1
  • 22
    • 84883054431 scopus 로고    scopus 로고
    • Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice
    • Okuda, R., Hagiwara, E., Baba, T., Kitamura, H., Kato, T., Ogura, T., Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice. Respir. Med. 107 (2013), 1431–1437.
    • (2013) Respir. Med. , vol.107 , pp. 1431-1437
    • Okuda, R.1    Hagiwara, E.2    Baba, T.3    Kitamura, H.4    Kato, T.5    Ogura, T.6
  • 27
    • 79960556065 scopus 로고    scopus 로고
    • Pirfenidone Clinical Study Group in J. The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial
    • Taniguchi, H., Kondoh, Y., Ebina, M., Azuma, A., Ogura, T., Taguchi, Y., Suga, M., Takahashi, H., Nakata, K., Sato, A., Sugiyama, Y., Kudoh, S., Nukiwa, T., Pirfenidone Clinical Study Group in J. The clinical significance of 5% change in vital capacity in patients with idiopathic pulmonary fibrosis: extended analysis of the pirfenidone trial. Respir. Res., 12, 2011, 93.
    • (2011) Respir. Res. , vol.12 , pp. 93
    • Taniguchi, H.1    Kondoh, Y.2    Ebina, M.3    Azuma, A.4    Ogura, T.5    Taguchi, Y.6    Suga, M.7    Takahashi, H.8    Nakata, K.9    Sato, A.10    Sugiyama, Y.11    Kudoh, S.12    Nukiwa, T.13
  • 32
    • 85006070790 scopus 로고    scopus 로고
    • Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study
    • Yamazaki, R., Nishiyama, O., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., Tohda, Y., Clinical features and outcomes of IPF patients hospitalized for pulmonary infection: a Japanese cohort study. PLoS One, 11, 2016, e0168164.
    • (2016) PLoS One , vol.11 , pp. e0168164
    • Yamazaki, R.1    Nishiyama, O.2    Sano, H.3    Iwanaga, T.4    Higashimoto, Y.5    Kume, H.6    Tohda, Y.7
  • 33
    • 84994528757 scopus 로고    scopus 로고
    • Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
    • King, C.S., Nathan, S.D., Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities. lancet Respir. Med. 5 (2017), 72–84.
    • (2017) lancet Respir. Med. , vol.5 , pp. 72-84
    • King, C.S.1    Nathan, S.D.2
  • 35
    • 38449102031 scopus 로고    scopus 로고
    • Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant
    • Shorr, A.F., Wainright, J.L., Cors, C.S., Lettieri, C.J., Nathan, S.D., Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur. Respir. J. 30 (2007), 715–721.
    • (2007) Eur. Respir. J. , vol.30 , pp. 715-721
    • Shorr, A.F.1    Wainright, J.L.2    Cors, C.S.3    Lettieri, C.J.4    Nathan, S.D.5
  • 36
    • 33645118315 scopus 로고    scopus 로고
    • Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
    • Lettieri, C.J., Nathan, S.D., Barnett, S.D., Ahmad, S., Shorr, A.F., Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129 (2006), 746–752.
    • (2006) Chest , vol.129 , pp. 746-752
    • Lettieri, C.J.1    Nathan, S.D.2    Barnett, S.D.3    Ahmad, S.4    Shorr, A.F.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.